This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.
Finn Willingham is co-chair of the NIHR Advanced Therapy Medicinal Product (ATMP) Group and Head of Advanced Therapy Treatment Centre Network Coordination.
Together with Nick Meade, Finn is leading on engagement activities with patients and the public related to ATMP research. The work they are undertaking aims to enable members of the public and patients to become more aware of, and involved in, ATMP studies.